Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegasys, Copegus, and Amantadine in Chronic HCV Relapsers (TRELA)
NCT00299923Phase 3Unknown
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Nov 2005
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a in chronic hepatitis C (CHC), sponsored by University Medical Center Hamburg-Eppendorf. Status: unknown.
02
Drugs
peginterferon alfa-2a
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT00299923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299923.